focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.40
Bid: 65.60
Ask: 65.80
Change: -0.20 (-0.30%)
Spread: 0.20 (0.305%)
Open: 64.80
High: 65.80
Low: 64.80
Prev. Close: 65.60
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) (Idox PLC)

5 Mar 2021 11:12

RNS Number : 3438R
IDOX PLC
05 March 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Idox plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Idox plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

4 March 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 0.1p in Idox plc

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0.000

Nil

0.000

(2) Cash-settled derivatives:

 

Nil

0.000

Nil

0.000

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0.000

Nil

0.000

 

TOTAL:

Nil

0.000

Nil

0.000

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(A) Interests held by the directors of Idox plc and their close relatives and related trusts:

 

Director

No. of ordinary shares of 0.1p each held

Percentage of issued share capital

Chris Stone

936,377

0.21%

David Meaden

468,139

0.11%

Robert Grubb

88,885

0.02%

Phil Kelly

105,263

0.02%

 

(B) Interests held as options or awards by directors of Idox plc under the Idox Long Term Incentive Plan 2019 ("LTIP") and under a matching share agreement entered into between the relevant director and Idox ("MSA") which have vested but where the director has not exercised their right to acquire or receive the shares:

 

Director

Scheme

Award date

No. of ordinary shares of 0.1p each under option / award (2)

Vesting date

Percentage of issued share capital

Robert Grubb

LTIP

18 March 2019

333,333

18 March 2020

0.07%

David Meaden

LTIP

12 March 2019

1,170,800

12 March 2020

0.3%

Chris Stone

MSA

11 March 2019

585,500

11 March 2019

0.13%

 

(C) Interests held as options or awards by directors of Idox plc under the Idox Long Term Incentive Plan 2019 ("LTIP") which have not yet vested:

 

Director

Scheme

Award date

No. of ordinary shares of 0.1p each under option / award (2)

Vesting date

Percentage of issued share capital

Robert Grubb

LTIP

18 March 2019

333,333

18 March 2021

0.07%

18 March 2019

333,334

18 March 2022

0.07%

LTIP

18 March 2020

108,024

18 March 2021

0.02%

18 March 2020

108,025

18 March 2022

0.02%

18 March 2020

108,025

18 March 2023

0.02%

David Meaden

LTIP

12 March 2019

1,170,800

12 March 2021

0.3%

12 March 2019

1,170,800

12 March 2022

0.3%

 

(2) The number shown in this column is the maximum number of ordinary shares which are capable of being acquired in connection with that option or award. The actual number of shares which may be acquired may be more or less, depending on performance against any applicable performance conditions.

 

(D) Interests of Idox Trustees Limited, in its capacity as trustee of the Idox plc Employee Benefit Trust

 

Class of relevant security

Ordinary shares of 0.1p each in Idox plc

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

3,522,022

0.79%

0

0.000%

(2) Cash-settled derivatives

0

0.000%

0

0.000%

(3) Stock-settled derivatives

0

0.000%

0

0.000%

 

 

 

Class of relevant security

Ordinary shares of 0.1p each in Idox plc

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

%

0

0.000%

(2) Cash-settled derivatives

0

0.000%

0

0.000%

(3) Stock-settled derivatives

0

0.000%

0

0.000%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 March 2021

Contact name:

Ruth Paterson

Telephone number:

03330111636

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUVAARARUORAR
Date   Source Headline
23rd Feb 20217:00 amRNSForm 8.3 - Idox plc
22nd Feb 20213:15 pmGNWForm 8.3 - [IDOX plc - Opening Declaration] - (HHL) - CORRECTION
22nd Feb 20213:11 pmGNWForm 8.3 - [IDOX plc - Opening Declaration] - (CGWL) - CORRECTION
22nd Feb 20212:05 pmRNSForm 8.5 (EPT/RI)
22nd Feb 20211:39 pmRNSForm 8.5 (EPT/RI) - Replacement
22nd Feb 20211:31 pmRNSForm 8.3 - IDOX Plc
22nd Feb 202112:51 pmGNWForm 8.3 - Idox plc
22nd Feb 202112:00 pmRNSForm 8.5 (EPT/RI) IDOX Plc
22nd Feb 202111:58 amGNWForm 8.3 - [IDOX plc - Opening Declaration] - (HHL)
22nd Feb 202111:49 amGNWForm 8.3 - [IDOX plc - Opening Declaration] - (CGWL)
22nd Feb 202110:34 amRNSForm 8.3 - IDOX Plc
22nd Feb 202110:31 amRNSForm 8.5 (EPT/RI)
19th Feb 20215:35 pmRNSForm 8.3 Disclosure
19th Feb 20215:12 pmRNSForm 8.3 - Idox Plc
19th Feb 20213:02 pmRNSForm 8.3 - Idox Plc
19th Feb 20212:45 pmGNWForm 8.3 - Octopus Investments - - IDOX plc
19th Feb 202111:26 amGNWForm 8.3 - Idox Plc
19th Feb 20217:39 amRNSStatement re Possible Offer
19th Feb 20217:00 amRNSStatement re Possible Offer
3rd Feb 20217:00 amRNSAGM Date & Dividend Payment Schedule
2nd Feb 20217:00 amRNSFY20 Results
19th Jan 20214:05 pmRNSExercise of Share Options & Total Voting Rights
19th Jan 20217:00 amRNSNotice of Final Results
2nd Dec 20207:00 amRNSContract Win
2nd Dec 20207:00 amRNSExercise of Share Options and Total Voting Rights
26th Nov 202011:37 amRNSInvestor presentation
17th Nov 20207:00 amRNSYear End Trading Update
27th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
22nd Oct 20205:35 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSAppointment of Head of Professional Services
14th Oct 20205:45 pmRNSReplacement: Exercise of Share Options & TVR
14th Oct 202011:51 amRNSHolding(s) in Company
14th Oct 20207:00 amRNSIdox Rebrand and Recent Progress with Idox Cloud
13th Oct 20207:00 amRNSExercise of Share Options & Total Voting Rights
23rd Sep 20205:30 pmRNSHolding(s) in Company
28th Aug 20207:00 amRNSDirectorate Changes
25th Aug 20207:00 amRNSExercise of Share Options & Total Voting Rights
16th Jul 20207:00 amRNSExercise of Share Options & Total Voting Rights
8th Jul 20201:58 pmRNSHolding(s) in Company
19th Jun 20207:00 amRNSGrant of Options
15th Jun 20207:00 amRNSHalf-year Report
28th May 202011:18 amRNSResult of AGM
19th May 20207:00 amRNSHalf Year Trading Update
1st May 20207:42 amRNSPosting of Annual Report and Notice of AGM
28th Apr 20204:33 pmRNSHolding(s) in Company
20th Apr 20208:01 amRNSProgressive publishes new research
14th Apr 20207:01 amRNSDirectorate Change
14th Apr 20207:00 amRNSFinal Results
30th Mar 20204:36 pmRNSPrice Monitoring Extension
23rd Mar 20207:00 amRNSNotice of Results Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.